NICOLE GREEN: Open Payments
NPI 1013268929 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 50 payments from 12 companies in 2025. Trend: 2023 $608 · 2024 $1,165 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $286 |
| ABBVIE INC. | 10 | $221 |
| AstraZeneca Pharmaceuticals LP | 6 | $178 |
| PFIZER INC. | 10 | $153 |
| Radius Health, Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Exact Sciences Corporation | 2 | $33 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $19 |
Products named: Ozempic, BREZTRI, UBRELVY, NURTEC ODT, Wegovy, QULIPTA, FARXIGA, MOUNJARO.
Industry payments across IN — which companies pay providers there.
